Showing results (141-150 of 325) with videos related to
Sort By:
Pageof 33
Thrombosis Research|July 1, 1990
Heparin-induced platelet aggregation. II. Dose/response relationships for two low molecular weight heparin fractions (CY 216 and CY 222)L D Brace, J FareedThrombosis Research|June 15, 1997
Vasomodulatory action of clopidogrel and ticlopidineL H Yang, J FareedSeminars in Thrombosis and Hemostasis|April 1, 1985
An objective assessment of the interaction of heparin and its fractions with human plateletsL D Brace, J FareedThrombosis Research|June 15, 1986
Heparin-induced platelet aggregation: dose/response relationships for a low molecular weight heparin derivative (PK 10169) and its subfractionsL D Brace, J FareedThe Annals of Thoracic Surgery|April 1, 1996
Aprotinin modulation of platelet activation in patients undergoing cardiopulmonary bypass operationsC Primack, J M Walenga, M J Koza, et al.Seminars in Thrombosis and Hemostasis|January 1, 1996
Plasma levels of the molecular markers of coagulation and fibrinolysis in patients with peripheral arterial diseaseA Strano, D Hoppensteadt, J M Walenga, et al.International Angiology : a Journal of the International Union of Angiology|May 28, 2011
Prophylaxis of venous thromboembolism: low molecular weight heparin compared to the selective anticoagulants rivaroxaban, dabigatran and fondaparinuxD Welzel, R Hull, J FareedActa Radiologica: Diagnosis|January 1, 1982
Contrast media induced serotonin release in human bloodZ Parvez, R Moncada, J FareedSeminars in Thrombosis and Hemostasis|November 5, 1999
Past, present and future considerations on low molecular weight heparin differentiation: an epilogueJ Fareed, S Haas, A SasaharThrombosis Research|April 1, 1993
Molecular weight profiling of low molecular weight heparins utilizing a heparinase degraded oligosaccharide mixture as a calibratorW Jeske, A Ahsan, J FareedPageof 33